Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-splenectomy lymphocytosis

S Juneja1, E Januszewicz, M Wolf

  • 1Haematology Department, Peter MacCallum Cancer Institute, Melbourne, Australia.

Clinical and Laboratory Haematology
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model" Neurobiol Dis. 46(3) (2012):663-72.

Neurobiology of disease·2025
Same author

A review of the potential for bacteriophages to effect antibiofilm activity, using selected examples.

Journal of applied microbiology·2023
Same author

Corticosteroid signaling at the brain-immune interface impedes coping with severe psychological stress.

Science advances·2019
Same author

Offensive waste valorisation in the UK: Assessment of the potentials for absorbent hygiene product (AHP) recycling.

Waste management (New York, N.Y.)·2019
Same author

Antibiofilm potential of purified environmental bacteriophage preparations against early stage Pseudomonas aeruginosa biofilms.

Journal of applied microbiology·2019
Same author

The effect of urinary Foley catheter substrate material on the antimicrobial potential of calixerene-based molecules.

Journal of applied microbiology·2017

Post-splenectomy lymphocytosis (PSL) is a common finding in patients after spleen removal, often persisting long-term. This study observed PSL in 23 patients, with no evidence of a monoclonal B cell population.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Splenectomy is a surgical procedure involving the removal of the spleen.
  • Hodgkin's disease is a type of lymphoma that affects the lymphatic system.
  • Post-splenectomy lymphocytosis (PSL) is an increase in lymphocyte count after spleen removal.

Purpose of the Study:

  • To describe the characteristics of post-splenectomy lymphocytosis (PSL).
  • To investigate the duration and nature of PSL in patients undergoing splenectomy for Hodgkin's disease.

Main Methods:

  • Retrospective analysis of 23 patients who underwent splenectomy.
  • Measurement of absolute lymphocyte counts.
  • Immunophenotyping of lymphocytes.
  • Longitudinal follow-up of patients.

Related Experiment Videos

Main Results:

  • A majority of patients (20/23) underwent splenectomy for Hodgkin's disease staging.
  • Absolute lymphocyte counts ranged from 4.0 to 8.7 x 10(9)/l.
  • Lymphocytosis was observed between 4-242 months post-splenectomy and remained stable during prolonged follow-up (median 50 months).
  • Immunophenotyping showed no monoclonal B cell population.

Conclusions:

  • Post-splenectomy lymphocytosis is a persistent finding in patients after splenectomy.
  • The observed lymphocytosis is likely reactive and not indicative of a lymphoproliferative disorder.
  • Further research may be needed to understand the exact mechanisms driving PSL.